A Novel Approach for Measuring the Burden of Uncomplicated Plasmodium falciparum Malaria: Application to Data from Zambia

Crowell, Valerie; Yukich, Joshua O.; Briët, Olivier J. T.; Ross, Amanda; Smith, Thomas A.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Measurement of malaria burden is fraught with complexity, due to the natural history of the disease, delays in seeking treatment or failure of case management. Attempts to establish an appropriate case definition for a malaria episode has often resulted in ambiguities and challenges because of poor information about treatment seeking, patterns of infection, recurrence of fever and asymptomatic infection. While the primary reason for treating malaria is to reduce disease burden, the effects of treatment are generally ignored in estimates of the burden of malaria morbidity, which are usually presented in terms of numbers of clinical cases or episodes, with the main data sources being reports from health facilities and parasite prevalence surveys. The use of burden estimates that do not consider effects of treatment, leads to under-estimation of the impact of improvements in case management. Official estimates of burden very likely massively underestimate the impact of the roll-out of ACT as first-line therapy across Africa. This paper proposes a novel approach for estimating burden of disease based on the point prevalence of malaria attributable disease, or equivalently, the days with malaria fever in unit time. The technique makes use of data available from standard community surveys, analyses of fever patterns in malaria therapy patients, and data on recall bias. Application of this approach to data from Zambia for 2009–2010 gave an estimate of 2.6 (95% credible interval: 1.5–3.7) malaria attributable fever days per child-year. The estimates of recall bias, and of the numbers of days with illness contributing to single illness recalls, could be applied more generally. To obtain valid estimates of the overall malaria burden using these methods, there remains a need for surveys to include the whole range of ages of hosts in the population and for data on seasonality patterns in confirmed case series.


Related Articles

  • 6-Oxopurine Phosphoribosyltransferase: A Target for the Development of Antimalarial Drugs. de Jersey, John; Holý, Antonín; Hocková, Dana; Naesens, Lieve; Keough, Dianne T.; Guddat, Luke W. // Current Topics in Medicinal Chemistry;Aug2011, Vol. 11 Issue 16, p2085 

    Malaria remains the most serious parasitic diseases affecting humans in the world today, resulting in 1-2 million fatalities each year. Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) are the predominant causative agents. Both are responsible for widespread mortality and morbidity and are a...

  • Ultra-Sensitive Detection of Plasmodium falciparum by Amplification of Multi-Copy Subtelomeric Targets. Hofmann, Natalie; Mwingira, Felista; Shekalaghe, Seif; Robinson, Leanne J.; Mueller, Ivo; Felger, Ingrid // PLoS Medicine;Mar2015, Vol. 12 Issue 3, p1 

    Background: Planning and evaluating malaria control strategies relies on accurate definition of parasite prevalence in the population. A large proportion of asymptomatic parasite infections can only be identified by surveillance with molecular methods, yet these infections also contribute to...

  • Anti-MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele-Specific Manner by Monocyte-Mediated Antibody-Dependent Cellular Inhibition. Galamo, Corine Demanga; Jafarshad, Ali; Blanc, Catherine; Druilhe, Pierre // Journal of Infectious Diseases;4/15/2009, Vol. 199 Issue 8, p1151 

    We investigated whether anti-merozoite surface protein-1 (MSP1) block 2 antibodies mediate the monocyte-dependent antibody-mediated cellular inhibition (ADCI) of Plasmodium falciparum. This study was performed because soluble molecules have been shown to trigger ADCI and because MSP1 block 2 is...

  • Public health system readiness to treat malaria in Odisha State of India. Hussain, Mohammad A.; Dandona, Lalit; Schellenberg, David // Malaria Journal;2013, Vol. 12 Issue 1, p1 

    Background: Early diagnosis and prompt treatment is a cornerstone of malaria control. In India, artemisinin combination therapy (ACT) became the first-line treatment for falciparum malaria and rapid diagnostic test (RDTs) kits were recommended for use at the grass-root level in the new malaria...

  • Statistical Properties of Parasite Density Estimators in Malaria. Hammami, Imen; Nuel, Grégory; Garcia, André // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Malaria is a global health problem responsible for nearly one million deaths every year around 85% of which concern children younger than five years old in Sub-Saharan Africa. In addition, around million clinical cases are declared every year. The level of infection, expressed as parasite...

  • Dose-Finding Study of the Efficacy of Fixed-Combination Artemether/Lumefantrine for the Treatment of Multidrug-Resistant Plasmodium falciparum Malaria in Thailand. Karbwang, J.; Na-Bangchang, K.; Thanavibul, A.; Mull, R.; Gathmann, I. // Clinical Drug Investigation;2000, Vol. 19 Issue 5, p343 

    Objective: To investigate the efficacy and tolerability of three different regimens of the fixed combination artemether/lumefantrine (artemether/benflumetol) in patients with multidrug-resistant Plasmodium falciparum malaria. Design: Randomised, double-blind, dose-finding study. Setting: Two...

  • Failure of Doxycycline as a Causal Prophylactic Agent against Plasmodium falciparum Malaria in Healthy Nonimmune Volunteers. Shmuklarsky, Moshe J.; Boudreau, Ellen F.; Pang, Lorrin W.; Smith, Joseph I.; Schneider, Imogene; Fleckenstein, Lawrence; Abdelrahim, Maged M.; Canfield, Craig J.; Schuster, Brian // Annals of Internal Medicine;2/15/94, Vol. 120 Issue 4, p294 

    Objective: To determine whether doxycycline, 100 mg administered as a single daily oral dose, is effective as a causal prophylactic agent, an agent active against the pre-erythrocytic liver stage of Plasmodium falciparum malaria parasites, in healthy nonimmune persons. If effective, the...

  • Halofantrine efficacy in non-immune children with imported acute Plasmodium falciparum malaria Infection. Hau, Isabelle; Seringe, Sophie; Aberrane, Said; De La Rocque, France; Delacourt, Christophe; Cohen, Robert; Reinert, Philippe; Ovetchkine, Philippe // European Journal of Pediatrics;2004, Vol. 163 Issue 1, p22 

    Unlabelled: A rising incidence of imported acute malaria has been observed in non-immune traveller children returning from the tropics to France. Halofantrine efficacy has been poorly assessed in non-immune children. In order to assess halofantrine efficacy in non-immune children...

  • Combination drugs for treatment of uncomplicated malaria in African children.  // Biomedical Market Newsletter;11/16/2011, Vol. 21, p721 

    The article reports on the findings of a study on the efficacy of artemisinin-based combination therapy drugs (ACTs) for uncomplicated malaria in African children. It states that ACTs have been effective in getting rid of the Plasmodium (P.) falciparum parasite that cause malaria in children for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics